Millet M

No ORCID on file · 1 paper in corpus

2023

Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.

EFSA journal. European Food Safety Authority ·doi:10.2903/j.efsa.2023.7744

Development of adverse outcome pathways (AOPs) for uterine adenocarcinoma can provide a practical tool to implement the EFSA-ECHA Guidance (2018) for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 …